NCT06012643

Subperiosteal Implants Constructed With Digital Technology

Status unknown Last updated 23 October 2023

What this trial tests

trial testing The purpose of this systematic review of case reports and case series was to evaluate the spectrum of subperiosteal implants for severely atrophied jaws using digital technology. in Alveolar Bone Loss in 23 participants. Status unknown.

Timeline

1 June 2023

Primary endpoint
20 October 2023

30 October 2023

Quick facts

Lead sponsor	Mansoura University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	23
Start date	1 June 2023
Primary completion	20 October 2023
Estimated completion	30 October 2023
Sites	1 location across Egypt

Drugs / interventions tested

• The purpose of this systematic review of case reports and case series was to evaluate the spectrum of subperiosteal implants for severely atrophied jaws using digital technology.

Conditions studied

• Alveolar Bone Loss — all drugs for Alveolar Bone Loss →

Sponsor

Mansoura University

Who can join

Adults 15 to 85, any sex, with Alveolar Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Atrophied jaw is a condition where there is insufficient bone quantity to place root form implants. Several treatment plans are available for treating atrophied jaws, including subperiosteal implants. Subperiosteal implants were introduced in the last century. Poor clinical results led those implants to be progressively abandoned. Recently, several Authors suggested a revival of subperiosteal implants as an alternative to regenerative procedures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.